Daclatasvir
Formulations: - Oral > Solid > tablet: 30 mg (as dihydrochloride); 60 mg (as dihydrochloride) Indications: - Chronic hepatitis C Source: EML workbook import
MOQ: 1
Kes0.00
Product image unavailable
Sofosbuvir
Vendor: Marketplace supplier
Formulations:
- Oral > Solid > tablet: 200 mg; 400 mg
Oral > Solid > granules: 200 mg in sachet
Indications:
- Chronic hepatitis C
Source: EML workbook import
Product metadata will be available once the catalog entry is complete.
Kes0.00
Availability
Supplier and price will be confirmed during RFQ.
Formulations:
- Oral > Solid > tablet: 200 mg; 400 mg
Oral > Solid > granules: 200 mg in sachet
Indications:
- Chronic hepatitis C
Source: EML workbook import
Similar Products
Daclatasvir + Sofosbuvir
Formulations: - Oral > Solid > tablet: 60 mg (as dihydrochloride) + 400 mg Indications: - Chronic hepatitis C Source: EML workbook import
MOQ: 1
Kes0.00
Glecaprevir + Pibrentasvir
Formulations: - Oral > Solid: 50 mg + 20 mg granules Oral > Solid > tablet: 100 mg + 40 mg Indications: - Chronic hepatitis C Source: EML workbook import
MOQ: 1
Kes0.00
Ravidasvir
Formulations: - Oral > Solid > tablet: 200 mg Indications: - Chronic hepatitis C Source: EML workbook import
MOQ: 1
Kes0.00
Sofosbuvir + Velpatasvir
Formulations: - Oral > Solid > tablet: 200 mg + 50 mg; 400 mg + 100 mg Oral > Solid > granules: 150 mg + 37.5 mg in sachet; 200 mg + 50 mg in sachet Indications: - Chronic hepatitis C Source: EML workbook import
MOQ: 1
Kes0.00
Sign Up to Our Newsletter→
Ready to amplify your rewards? Drop your email and we'll be in touch soon.